Berentzen-Gruppe (BEZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Consolidated revenues for 2025 were EUR 162.9 million, significantly below the previous year due to market decline and the sale of the Grüneberg site.
Spirits market saw a third consecutive year of volume decline, with no trend reversal in sight.
Despite revenue and profit declines, gross profit margin was maintained at prior-year levels (44.0%).
Consolidated profit turned positive, with a significant increase compared to the previous year.
The new corporate strategy, Berentzen Evolve 2030, was introduced to address market challenges and drive future growth.
Financial highlights
Revenues decreased by 10.7% year-over-year to EUR 162.9 million.
Consolidated profit was EUR 2.4 million, a turnaround from a EUR 1.3 million loss in 2024, mainly due to the absence of a EUR 4.8 million one-off loss from the Grüneberg sale.
EBITDA dropped 11.2% to EUR 17.1 million; EBIT declined 19.9% to EUR 8.5 million.
Net debt reduced to EUR 3.7 million at year-end 2025, with an improved dynamic gearing ratio of 0.21.
Dividend proposal of EUR 0.11 per share, matching last year, with a yield of 3.0%.
Outlook and guidance
2026 revenue guidance: EUR 163–173 million, indicating expected growth.
EBITDA forecast: EUR 16.1–18.1 million; EBIT forecast: EUR 7.0–9.0 million.
Major projects under the Berentzen Evolve 2030 initiative are set to drive future growth.
2026 is positioned as a transitional year with significant investments and strategic projects.
Latest events from Berentzen-Gruppe
- Profitability surged in H1 2024 despite flat sales, with Grüneberg divestment set to lift margins.BEZ
Q2 20241 Feb 2026 - Record EBIT and margin gains in 2024 set the stage for double-digit growth in 2025.BEZ
Q4 202425 Dec 2025 - Revenue and profit declined year-over-year; outlook lowered amid challenging market conditions.BEZ
Q3 202523 Oct 2025 - Revenue and earnings declined, but profit turned positive and outlook remains cautiously optimistic.BEZ
Q2 202514 Aug 2025 - Adjusted EBIT and EBITDA surged despite stable revenues and one-off impairment losses.BEZ
Q3 202413 Jun 2025 - Revenue down 4.7% in Q1 2025; outlook for full year remains positive despite market volatility.BEZ
Q1 20255 Jun 2025